AI-ECG Tracker
Shenzhen Carewell Electronics Co., Ltd. • Cardiovascular • 03/20/2020
Device Purpose
The AI-ECG Tracker is a software system designed to assist healthcare professionals in assessing cardiac arrhythmias by analyzing ambulatory ECG data from adult patients. It utilizes a pre-trained, locked convolutional neural network for beat classification as part of its automated ECG interpretation, providing advisory diagnostic information to clinicians.
Summary
The AI-ECG Tracker is a software system designed for qualified healthcare professionals in hospitals and healthcare facilities to aid in the assessment of cardiac arrhythmias in adult patients (age 22 and older) who do not have pacemakers. It processes ECG data acquired from various compatible devices, such as Holter monitors, event recorders, and 12-lead ambulatory ECG systems. The system performs beat-by-beat ECG signal analysis, including QRS detection, identification of supraventricular and ventricular ectopic beats, QRS feature extraction, interval and heart rate measurement, and overall rhythm analysis. The AI-ECG Tracker operates as a distributed auto-analysis system where ECG waveform data is uploaded to a server for automated interpretation, with results then downloaded to a Physician Diagnostic Client for review, modification, and confirmation. While a machine learning process, specifically a convolutional neural network (CNN), is utilized during the development phase for its AI-based beat classification algorithm, this model is locked in the final product, meaning the marketed device does not possess active machine learning or self-learning capabilities. The system's interpretations are intended as advisory information, complementing the clinician's expertise and other diagnostic data, and it is not for use in life-supporting systems or as the sole basis for diagnosis.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the performance of the locked CNN-based beat classification model compare to traditional, non-AI algorithms in terms of sensitivity and specificity for various arrhythmia types, especially in complex cases?; What specific ECG features and parameters are extracted by the QRS feature extraction module, and how do these contribute to the accuracy of the subsequent arrhythmia analysis?; Given the distributed nature of the system (server-client), what are the data security and privacy measures implemented for the transmission and storage of sensitive patient ECG data?; What was the diversity of the dataset (e.g., demographic, types of arrhythmias, signal quality) used to train and validate the CNN model for beat classification, and how does this impact its generalizability to different patient populations?; Since the AI model is locked, what is the process for updating or improving the beat classification algorithm as new ECG data or research findings become available?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly